Bone Therapeutics

Headquartered at the Biopôle of Gosselies (South of Brussels, Belgium), Bone Therapeutics is a leading international biotechnology company specialized in the treatment of osteo-articular diseases using cell therapy. With its proprietary cell technology platform, the Company is developing innovative cell products for the repair and regeneration of bone and joint tissues. The Company’s leading position in skeletal tissue reparation is supported by an outstanding knowledge of the bone physiology and pathophysiology, the pioneering works of its founders in stem cell transplantation in humans and a long-standing expertise in cell therapy clinical trials and regulatory affairs.
Company Growth (employees)
Charleroi, BE
Size (employees)
101 (est)
Bone Therapeutics was founded in 2006 and is headquartered in Charleroi, BE

Key People/Management at Bone Therapeutics

Jean-Luc Vandebroek

Jean-Luc Vandebroek

Chief Financial Officer
Thomas Lienard

Thomas Lienard

MBA – Chief Executive Officer
Guy Heynen

Guy Heynen

MD – Chief Clinical and Regulatory Officer
Benoît Champluvier

Benoît Champluvier

PhD – Chief Technology and Manufacturing Officer
Nora Meskini

Nora Meskini

Director of Clinical Operations

Bone Therapeutics Office Locations

Bone Therapeutics has an office in Charleroi
Charleroi, BE (HQ)
37 Rue Auguste Piccard
Show all (1)

Bone Therapeutics Financials and Metrics

Bone Therapeutics Financials


Market capitalization (22-Mar-2017)

52.3 b

Closing share price (22-Mar-2017)

Bone Therapeutics's current market capitalization is €52.3 b.
Show all financial metrics

Bone Therapeutics Market Value History

Bone Therapeutics's Web-traffic and Trends

Bone Therapeutics Online and Social Media Presence

Bone Therapeutics Company Life and Culture

You may also be interested in